Mereo Biopharma Group PLC Share Price Today: Live Updates & Key Insights
Mereo Biopharma Group PLC share price today is $0.3338, up -5.18%. The stock opened at $0.3585 against the previous close of $0.3607, with an intraday high of $0.3734 and low of $0.3366.
Mereo Biopharma Group PLC Share Price Chart
Mereo Biopharma Group PLC
Mereo Biopharma Group PLC Share Price Performance
Mereo Biopharma Group PLC Institutional Holdings
Mereo Biopharma Group PLC Market Status
Mereo Biopharma Group PLC Fundamentals
Market Cap 57.40 M
PB Ratio 1.1918
PE Ratio 0.0
Enterprise Value 7.24 M
Total Assets 45.92 M
Volume 1826348
Mereo Biopharma Group PLC Company Financials
About Mereo Biopharma Group PLC & investment objective
Company Information Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. It develops Etigilimab, an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for use in the treatment of tumors. The company is also developing Navicixizumab, which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod, a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole, an oral aromatase inhibitor, which is in Phase 2 trials for use in the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab, an antibody for the treatment of osteogenesis imperfecta; and Alvelestat, an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a license agreement with Feng Biosciences for the development and commercialization of navicixizumab; license agreement with ReproNovo for the development and commercialization of leflutrozole; and licensing agreement with AstraZeneca. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, United Kingdom.
Organisation Biotechnology
Employees 36
Industry Biotechnology
CEO Dr. Denise Vera Scots-Knight Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Mereo Biopharma Group PLC FAQs
What is the share price of Mereo Biopharma Group PLC today?
The current share price of Mereo Biopharma Group PLC is $0.3338.
Can I buy Mereo Biopharma Group PLC shares in India?
Yes, Indian investors can buy Mereo Biopharma Group PLC shares by opening an international trading and demat account with Motilal Oswal.
How to buy Mereo Biopharma Group PLC shares in India?
You can easily invest in Mereo Biopharma Group PLC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Mereo Biopharma Group PLC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Mereo Biopharma Group PLC.
Can I buy fractional shares of Mereo Biopharma Group PLC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Mereo Biopharma Group PLC?
Mereo Biopharma Group PLC has a market cap of $57.40 M.
In which sector does Mereo Biopharma Group PLC belong?
Mereo Biopharma Group PLC operates in the Biotechnology sector.
What documents are required to invest in Mereo Biopharma Group PLC stocks?
To invest, you typically need:
What is the PE and PB ratio of Mereo Biopharma Group PLC?
The PE ratio of Mereo Biopharma Group PLC is N/A and the PB ratio is 1.19.